Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Fifth Third Wealth Advisors LLC

Fifth Third Wealth Advisors LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 44.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,199 shares of the medical equipment provider’s stock after acquiring an additional 371 shares during the period. Fifth Third Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $479,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently made changes to their positions in the company. Baystate Wealth Management LLC lifted its stake in shares of Intuitive Surgical by 150.0% in the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 45 shares during the period. MCF Advisors LLC lifted its stake in shares of Intuitive Surgical by 108.1% in the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 40 shares during the period. Able Wealth Management LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. Atticus Wealth Management LLC lifted its stake in shares of Intuitive Surgical by 85.4% in the 4th quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 41 shares during the period. Finally, MeadowBrook Investment Advisors LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded up $2.55 during trading hours on Thursday, hitting $445.11. The company had a trading volume of 1,225,971 shares, compared to its average volume of 1,514,231. The firm has a market capitalization of $157.88 billion, a P/E ratio of 80.34, a price-to-earnings-growth ratio of 5.71 and a beta of 1.39. The firm’s fifty day moving average is $400.81 and its 200-day moving average is $381.34. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $445.79.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.10. The firm had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The company’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.00 EPS. Analysts anticipate that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Analyst Ratings Changes

ISRG has been the topic of a number of research reports. The Goldman Sachs Group initiated coverage on shares of Intuitive Surgical in a report on Thursday, May 30th. They issued a “buy” rating and a $500.00 target price on the stock. Stifel Nicolaus boosted their target price on shares of Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, April 8th. Robert W. Baird dropped their target price on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a report on Friday, April 19th. Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a report on Friday, April 19th. Finally, Piper Sandler boosted their target price on shares of Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a report on Friday, April 19th. Five research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $403.67.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the business’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total value of $589,484.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, EVP Robert Desantis sold 1,498 shares of the company’s stock in a transaction on Friday, April 26th. The shares were sold at an average price of $369.92, for a total transaction of $554,140.16. Following the completion of the sale, the executive vice president now directly owns 5,507 shares of the company’s stock, valued at approximately $2,037,149.44. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total transaction of $589,484.00. The disclosure for this sale can be found here. Insiders sold 17,956 shares of company stock valued at $6,927,011 over the last ninety days. Corporate insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.